Stefan Kostense

A fit-for-purpose strategy for the risk-based immunogenicity testing of biotherapeutics: a European industry perspective.

Daniel Kramer, Claudia Berger, Cathelijne Kloks, 2015, Journal of immunological methods.

Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy Vectors

Jaap Goudsmit, Stefan Kostense, S. Kostense, 2003, Journal of Clinical Microbiology.

Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study

Albert Hofman, Silvan Licher, Reem Waziry, 2020, Brain : a journal of neurology.

Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue.

Stefan Kostense, S. Kostense, F. Miedema, 2002, Trends in immunology.

High viral burden in the presence of major HIV‐specific CD8+ T cell expansions: evidence for impaired CTL effector function

Stefan Kostense, D. Baarle, S. Kostense, 2001, European journal of immunology.